Description
The last session of the series will address revascularization. This session will cover GLASS, its relationship to revascularization outcomes, and its current limitations. The growing impact of pedal artery disease in clinical practice will also be discussed. Finally, the panelists will discuss the latest data on the risks and benefits of drug elution in the CLTI population.

Faculty
John White, MD
Joseph Mills, MD
Michael Conte, MD

Target Audience
Vascular Surgeons
Vascular Trainee
General Surgery Residents
Medical Students
Vascular Nurses
Physician Assistants
Nurse Practitioners
Vascular Technologists
Hospital and Practice Administrators
Other Types of Physicians